Back to search

Article

The formyl peptide receptor 2 regulates microglial phenotype through immunometabolism : implications for Alzheimer's disease

2019-01-01

Abstract excerpt

Microglia are key players in the pathology of Alzheimer’s disease (AD), driving chronic inflammation, oxidative stress, and the altered metabolism seen in the brains of patients. With clinical trials continuing to fail, new approaches towards drug development are critical. Strategies to reduce microglial activation may therefore be a viable therapeutic approach to tackling AD. Formyl peptide receptor 2 (Fpr2), whi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b8228856-1ca2-5211-984e-ba8b5fe1a220
DOI
10.34737/qy292
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The formyl peptide receptor 2 regulates microglial phenotype through immunometabolism : implications for Alzheimer's diseaseDOI 10.34737/qy292
Select a neighboring publication to make it the new centre.